Characteristics of the beta myosin heavy chain gene Ala26Val mutation in a Chinese family with hypertrophic cardiomyopathy

European Journal of Internal Medicine

Volumn 16, Issue 5, 2005, Pages 328-333

  Liu, Sheng Xiang ^a   Hu, Shen Jiang ^a   Sun, Jian ^a   Wang, Jing ^b   Wang, Xi Tian ^a   Jiang, Yan ^b   Cai, Jing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Cardiomyopathy; Genetics; Hypertrophy; Mutation

Indexed keywords

ALANINE; BRAIN NATRIURETIC PEPTIDE; DNA FRAGMENT; FLUORESCENT DYE; GENOMIC DNA; MYOSIN HEAVY CHAIN; TROPONIN T; VALINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DNA PURIFICATION; DNA SEQUENCE; EXON; FAMILY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MISSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 28744445655     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.02.008     Document Type: Article

References (25)

1. P. Richardson, W. McKenna, M. Bristow, B. Mautner, J. O'Connell, and B. Maisch Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task force on the definition and classification of cardiomyopathies Circulation 93 1996 841 842
2. J.A. Towbin Molecular genetics of hypertrophic cardiomyopathy Curr Cardiol Rep 2 2000 134 140
3. A.J. Marian, and R. Roberts The molecular genetic basis for hypertrophic cardiomyopathy J Mol Cell Cardiol 33 2001 655 670
4. A.J. Marian Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy Lancet 355 2000 58 60
5. B.J. Maron Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Cardiol Rev 10 2001 173 181
6. K.L. Vikstrom, and L.A. Leinwand Contractile protein mutations and heart disease Curr Opin Cell Biol 8 1996 97 105
7. F. Ohsuzu, S. Katsushika, M. Akanuma, H. Nakamura, H. Harada, and M. Satoh Hypertrophic obstructive cardiomyopathy due to a novel T-to-A transition at codon 624 in the beta-myosin heavy chain (Beta-MHC) gene possible related to the sudden death Int J Cardiol 26 1997 203 209
8. A.J. Marian, and R. Roberts Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death J Cardiovasc Electrophysiol 9 1998 88 99
9. Y.B. Zou, J.Z. Wang, P.Z. Wu, W.Y. Zhen, S.L. Lu, and L. Song Ala26Val mutation in beta myosin heavy chain gene: a hot spot mutation in Chinese hypertrophic cardiomyopathy Chin J Cardiol 30 2002 473 476
10. L. Song, R. Xu, G.R. Wu, Y.B. Zou, J.Z. Wang, and W.Y. Zhen The genotype-phenotype correlation of the beta-myosin heavy chain gene Arg663Cys and Arg663His mutation in familial hypertrophic cardiomyopathy Chin J Cardiol 30 2002 131 135
11. M. Yoshibayashi, T. Kamiya, Y. Saito, and H. Matsuo Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy N Eng J Med 329 1993 433 434
12. P. Charron, O. Dubourg, M. Desnos, R. Isnard, A. Hagege, and A. Millaire Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population Circulation 96 1997 214 219
13. C.C. Liew, M.J. Sole, K. Yamaguchi-Takihara, B. Kellam, D.H. Anderson, and L.P. Lin Complete sequence and organization of the human cardiac β-myosin heavy chain gene Nucleic Acids Res 18 1990 3647 3651
14. M.J. Ackerman, S.I. VanDriest, S.R. Ommen, M.L. Will, R.A. Nishimura, and A.L. Tajik Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective J Am Coll Cardiol 39 2002 2042 2048
15. J.J. Seilhamer, A. Arfsten, J.A. Miller, P. Lundquist, R.M. Scarborough, and J.A. Lewicki Human and canine gene homologs of porcine brain natriuretic peptide Biochem Biophys Res Commun 165 1989 650 658
16. B. Gerull, K.J. Osterziel, C. Witt, R. Dietz, and L. Thierfelder A rapid protocol for cardiac troponin T gene mutation detection in familial hypertrophic cardiomyopathy Hum Mutat 11 1998 179 182
17. P. Richard, P. Charron, L. Carrier, C. Ledeuil, T.C. Pichereau, and A. Benaiche Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2003 2227 2232
18. J. Erdmann, S. Daehmlow, S. Wischke, M. Senyuva, U. Werner, and J. Raible Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy Clin Genet 64 2003 339 349
19. J.G. Crilley, E.A. Bochm, E. Blair, B. Rajagopalan, A.M. Blamire, and P. Styles Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy J Am Coll Cardiol 41 2003 1776 1782
20. Q. Wang, C.L. Moncman, and D.A. Winkelmann Mutations in the motor domain modulate myosin activity and myofibril organization J Cell Sci 116 2003 4227 4238
21. A. Luchner, J.C. Burnett, M. Jougasaki, H.W. Hense, I.M. Heid, and F. Muders Evaluation of brain natriuretic peptide as a marker of left ventricular dysfunction and hypertrophy in the population J Hypertens 18 2000 1121 1128
22. T. Nakamura, K. Sakamoto, T. Yomano, M. Kikkawa, K. Zen, and T. Hikosaka Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 1657 1663
23. B.J. Maron, J. Shirani, L.C. Poliac, R. Mathenge, W.C. Roberts, and F.O. Mueller Sudden death in young competitive athletes: clinical, demographic and pathological profiles JAMA 276 1996 199 204
24. E. Braunwald, C.E. Seidman, and U. Sigwart Contemporary evaluation and management of hypertrophic cardiomyopathy Circulation 106 2002 1312 1316
25. B.J. Maron, N.A. Mark Estes III, M.S. Maron, A.K. Almquist, M.S. Link, and J.E. Udelson Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy Circulation 107 2003 2872 2880